{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:49:35Z","timestamp":1794469775344,"version":"4.9.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2024.05.068","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:55:29Z","timestamp":1721688929000},"page":"126020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Vaccine value profile for schistosomiasis"],"prefix":"10.1016","volume":"64","author":[{"given":"Gavin","family":"Yamey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaci Kennedy","family":"McDade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Diemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebayo J.","family":"Molehin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rollinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Tendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne P.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl M.","family":"Zellweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.068_b0005","first-page":"23","article-title":"Vaccines for human schistosomiasis: recent progress, new developments and future prospects","author":"Molehin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2024.05.068_b0010","unstructured":"World Health Organization. Schistosomiasis n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis (accessed July 27, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.vaccine.2024.05.068_b0020","doi-asserted-by":"crossref","first-page":"e3296","DOI":"10.1371\/journal.pntd.0003296","article-title":"The relationship between water, sanitation and schistosomiasis: a systematic review and meta-analysis","volume":"8","author":"Grimes","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0025","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/S2542-5196(20)30129-7","article-title":"Prevalence and distribution of schistosomiasis in human, livestock, and snail populations in northern Senegal: a One Health epidemiological study of a multi-host system","volume":"4","author":"L\u00e9ger","year":"2020","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.vaccine.2024.05.068_b0030","series-title":"Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.vaccine.2024.05.068_b0035","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1073\/pnas.1221509110","article-title":"Identifying host species driving transmission of schistosomiasis japonica, a multihost parasite system, in China","volume":"110","author":"Rudge","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2024.05.068_b0040","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3201\/eid2606.200107","article-title":"Multihost transmission of Schistosoma mansoni in Senegal, 2015\u20132018","volume":"26","author":"Catalano","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110711118","article-title":"Spillover, hybridization, and persistence in schistosome transmission dynamics at the human\u2013animal interface","volume":"118","author":"Borlase","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2024.05.068_b0050","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.05.068_b0055","series-title":"Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.vaccine.2024.05.068_b0060","article-title":"WHO guidelines on the control and elimination of schistosomiasis","volume":"2022","author":"Lo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0065","first-page":"1","article-title":"An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: the time is now","volume":"115","author":"Bustinduy","year":"2022","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0070","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/microorganisms9081776","article-title":"Hybridized zoonotic schistosoma infections result in hybridized morbidity profiles: a clinical morbidity study amongst co-infected human populations of senegal","volume":"9","author":"Fall","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2024.05.068_b0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2334-10-227","article-title":"The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment","volume":"10","author":"Koukounari","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0080","first-page":"4","article-title":"Asian schistosomiasis: current status and prospects for control leading to elimination","author":"Gordon","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0085","first-page":"7","article-title":"Imported Schistosomiasis: a new public health challenge for China","author":"Wang","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijpara.2016.02.006","article-title":"Female genital schistosomiasis (FGS): from case reports to a call for concerted action against this neglected gynaecological disease","volume":"46","author":"Christinet","year":"2016","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0095","doi-asserted-by":"crossref","first-page":"e0007025","DOI":"10.1371\/journal.pntd.0007025","article-title":"Female genital schistosomiasis and HIV\/AIDS: reversing the neglect of girls and women","volume":"13","author":"Hotez","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000210614.45212.0a","article-title":"Association between genital schistosomiasis and HIV in rural Zimbabwean women","volume":"20","author":"Kjetland","year":"2006","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.vaccine.2024.05.068_b0105","unstructured":"Institute for Health Metrics and Evaluation. Schistosomiasis \u2014 Level 3 cause. Inst Health Metr Eval 2020. https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/schistosomiasis-level-3-cause (accessed July 27, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.actatropica.2010.03.005","article-title":"Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger","volume":"115","author":"Garba","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2024.05.068_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1179\/136485906X105552","article-title":"Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria","volume":"100","author":"Odogwu","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pt.2013.02.001","article-title":"Schistosomiasis in African infants and preschool children: let them now be treated!","volume":"29","author":"Stothard","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jtbi.2017.08.015","article-title":"Heterogeneity in schistosomiasis transmission dynamics","volume":"432","author":"Mari","year":"2017","journal-title":"J Theor Biol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635869","article-title":"Schistosomiasis morbidity hotspots: roles of the human host, the parasite and their interface in the development of severe morbidity","volume":"12","author":"Mawa","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0135","doi-asserted-by":"crossref","first-page":"e0009083","DOI":"10.1371\/journal.pntd.0009083","article-title":"Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: a systematic review and meta-analysis","volume":"15","author":"Ayabina","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0140","unstructured":"World Health Organization Strategy, Diseases M for P, Team VC. Report of the WHO informal consultation on the use of praziquantel during pregnancy\/lactation and albendazole\/mebendazole in children under 24 months: Geneva, 8-9 April 2002 2003:WHO\/CDS\/CPE\/PVC\/2002.4."},{"key":"10.1016\/j.vaccine.2024.05.068_b0145","doi-asserted-by":"crossref","first-page":"e2312","DOI":"10.1371\/journal.pntd.0002312","article-title":"Exploring gender dimensions of treatment programmes for neglected tropical diseases in Uganda","volume":"7","author":"Rilkoff","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0150","unstructured":"World Health Organization. Incorporating intersectional gender analysis into research on infectious diseases of poverty: a toolkit for health researchers 2020."},{"key":"10.1016\/j.vaccine.2024.05.068_b0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-3156.2009.02273.x","article-title":"Association between socio economic status and schistosomiasis infection in Jinja District, Uganda","volume":"14","author":"Muhumuza","year":"2009","journal-title":"Trop Med Int Health TM IH"},{"key":"10.1016\/j.vaccine.2024.05.068_b0160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJMra012396","article-title":"Schistosomiasis","volume":"346","author":"Ross","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0165","doi-asserted-by":"crossref","first-page":"20220274","DOI":"10.1098\/rstb.2022.0274","article-title":"Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective","volume":"378","author":"D\u00edaz","year":"2023","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.vaccine.2024.05.068_b0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40249-017-0286-2","article-title":"Controlling schistosomiasis with praziquantel: how much longer without a viable alternative?","volume":"6","author":"Bergquist","year":"2017","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.vaccine.2024.05.068_b0175","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/cid\/ciw506","article-title":"Reduced efficacy of Praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration","volume":"63","author":"Crellen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0180","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S1473-3099(16)00175-4","article-title":"Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study","volume":"16","author":"Boissier","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40249-020-00736-w","article-title":"An outbreak of intestinal schistosomiasis, alongside increasing urogenital schistosomiasis prevalence, in primary school children on the shoreline of Lake Malawi, Mangochi District","volume":"9","author":"Kayuni","year":"2020","journal-title":"Malawi Infect Dis Poverty"},{"key":"10.1016\/j.vaccine.2024.05.068_b0190","first-page":"173","article-title":"Outbreak of intestinal schistosomiasis in the Senegal River Basin","volume":"70","author":"Talla","year":"1990","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.vaccine.2024.05.068_b0195","unstructured":"O\u2019Ferrall A, Baxter H, Hull SKA is an academic trainee doctor working in, School UH graduated from LM, Biology with a M degree in, Parasites C of, et al. An outbreak of intestinal schistosomiasis: what lies ahead for Malawi? BugBitten 2020. https:\/\/blogs.biomedcentral.com\/bugbitten\/2020\/09\/11\/an-outbreak-of-intestinal-schistosomiasis-what-lies-ahead-for-malawi\/ (accessed July 27, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0200","first-page":"119","article-title":"Current understanding of immunity against schistosomiasis: impact on vaccine and drug development","volume":"11","author":"Molehin","year":"2020","journal-title":"Res Rep Trop Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0205","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)66457-4","article-title":"Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis","volume":"365","author":"King","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.05.068_b0210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/pim.12087","article-title":"Immunology of human schistosomiasis","volume":"36","author":"Colley","year":"2014","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0215","doi-asserted-by":"crossref","first-page":"e0008098","DOI":"10.1371\/journal.pntd.0008098","article-title":"Cost of interventions to control schistosomiasis: a systematic review of the literature","volume":"14","author":"Salari","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0220","doi-asserted-by":"crossref","first-page":"e2350","DOI":"10.1371\/journal.pntd.0002350","article-title":"Health access livelihood framework reveals potential barriers in the control of Schistosomiasis in the Dongting lake area of Hunan Province","volume":"7","author":"Balen","year":"2013","journal-title":"China PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0225","doi-asserted-by":"crossref","first-page":"e0004397","DOI":"10.1371\/journal.pntd.0004397","article-title":"Productivity loss related to neglected tropical diseases eligible for preventive chemotherapy: a systematic literature review","volume":"10","author":"Lenk","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13071-021-05147-w","article-title":"Estimating the financial impact of livestock schistosomiasis on traditional subsistence and transhumance farmers keeping cattle, sheep and goats in northern Senegal","volume":"15","author":"Adeyemo","year":"2022","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2024.05.068_b0235","unstructured":"World Health Organization. Diagnostic target product profiles for monitoring, evaluation and surveillance of schistosomiasis control programmes; 2021."},{"key":"10.1016\/j.vaccine.2024.05.068_b0240","unstructured":"World Health Organization. WHO guideline on control and elimination of human schistosomiasis; 2022."},{"key":"10.1016\/j.vaccine.2024.05.068_b0245","doi-asserted-by":"crossref","first-page":"e0006717","DOI":"10.1371\/journal.pntd.0006717","article-title":"The design of schistosomiasis monitoring and evaluation programmes: the importance of collecting adult data to inform treatment strategies for Schistosoma mansoni","volume":"12","author":"Toor","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0250","unstructured":"World Health Organization = Organisation mondiale de la Sant\u00e9. Weekly Epidemiological Record, 2023, vol. 98, 04 [full issue]. Wkly Epidemiol Rec Relev\u00e9 \u00c9pid\u00e9miologique Hebd 2023;98:41\u201352."},{"key":"10.1016\/j.vaccine.2024.05.068_b0255","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4269\/ajtmh.1996.55.109","article-title":"Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects","volume":"55","author":"Butterworth","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0260","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1977.26.702","article-title":"Schistosoma Mansoni and S. Haematobium Infections in Egypt: II. Quantitative Parasitological Findings at Necropsy","volume":"26","author":"Cheever","year":"1977","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.apar.2016.06.003","article-title":"Studies of the transmission dynamics, mathematical model development and the control of Schistosome Parasites by mass drug administration in Human communities","volume":"94","author":"Anderson","year":"2016","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0270","doi-asserted-by":"crossref","first-page":"e0006043","DOI":"10.1371\/journal.pntd.0006043","article-title":"Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis","volume":"11","author":"Burnim","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pt.2018.10.005","article-title":"Advancing the development of a human schistosomiasis vaccine","volume":"35","author":"Hotez","year":"2019","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0285","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.vaccine.2015.12.032","article-title":"Workshop report: Schistosomiasis vaccine clinical development and product characteristics","volume":"34","author":"Mo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.068_b0290","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/trstmh\/trx047","article-title":"Should we be treating animal schistosomiasis in Africa? The need for a One Health economic evaluation of schistosomiasis control in people and their livestock","volume":"111","author":"Gower","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0295","first-page":"473","article-title":"Field assessment of recombinant Schistosoma japonicum 26 kDa glutathione S-transferase in Chinese water buffaloes","volume":"34","author":"He","year":"2003","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2024.05.068_b0300","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-3024.2005.00784.x","article-title":"Prospects for development of a transmission blocking vaccine against Schistosoma japonicum - PubMed","volume":"27","author":"McManus","year":"2005","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0305","unstructured":"World Health Organization. WHO launches new guideline for the control and elimination of human schistosomiasis n.d. https:\/\/www.who.int\/news\/item\/22-02-2022-who-launches-new-guideline-for-the-control-and-elimination-of-human-schistosomiasis (accessed July 27, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0310","unstructured":"World Health Organization. Schistosomiasis (Bilharzia) n.d. https:\/\/www.who.int\/health-topics\/schistosomiasis (accessed July 27, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0315","unstructured":"National Institute of Allergy and Infectious Diseases. Schistosomiasis Resource Center n.d. https:\/\/www.niaid.nih.gov\/research\/schistosomiasis-resource-center (accessed September 26, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0320","doi-asserted-by":"crossref","first-page":"taab004","DOI":"10.1093\/jtm\/taab004","article-title":"Helminth infections in the US military: from strongyloidiasis to schistosomiasis","volume":"28","author":"Lindrose","year":"2021","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0325","doi-asserted-by":"crossref","first-page":"e1495","DOI":"10.7205\/MILMED-D-15-00269","article-title":"Clinical report: Schistosomiasis exposure in U.S. service personnel during whitewater rafting on the Nile River in Jinja, Uganda","volume":"181","author":"Maluil","year":"2016","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0330","unstructured":"Bill & Melinda Gates Foundation. Neglected Tropical Diseases. Bill Melinda Gates Found n.d. https:\/\/www.gatesfoundation.org\/our-work\/programs\/global-health\/neglected-tropical-diseases (accessed September 26, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0335","unstructured":"Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield\u00ae anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa. VASA Proj Fact Sheet 2023. https:\/\/cordis.europa.eu\/project\/id\/815643 (accessed September 26, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0340","unstructured":"Schistosomiasis Control Initiative. Our work. SCI n.d. https:\/\/schistosomiasiscontrolinitiative.org\/our-work (accessed September 26, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0345","unstructured":"International Vaccine Institute. Schistosomiasis n.d. https:\/\/www.ivi.int\/what-we-do\/disease-areas\/schistosomiasis\/ (accessed September 26, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0350","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12639-021-01387-w","article-title":"A comprehensive and critical overview of schistosomiasis vaccine candidates","volume":"45","author":"Al-Naseri","year":"2021","journal-title":"J Parasit Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0355","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.vaccine.2016.03.079","article-title":"Advancing a vaccine to prevent human schistosomiasis","volume":"34","author":"Merrifield","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.068_b0360","first-page":"12","article-title":"Immunological considerations for schistosoma vaccine development: transitioning to endemic settings","author":"Driciru","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0365","first-page":"105","article-title":"A lung model of schistosome immunity in mice","volume":"87","author":"von Lichtenberg","year":"1977","journal-title":"Am J Pathol"},{"issue":"128","key":"10.1016\/j.vaccine.2024.05.068_b0370","first-page":"1880","article-title":"Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement","volume":"1982","author":"Sher","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.vaccine.2024.05.068_b0375","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/252503a0","article-title":"Antibody-dependent cell-mediated damage to schistosomula in vitro","volume":"252","author":"Butterworth","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.05.068_b0380","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4269\/ajtmh.1985.34.341","article-title":"Effect of a cryopreserved live vaccine on resistance in mice with a pre-existing Schistosoma mansoni infection","volume":"34","author":"Lewis","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0385","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4269\/ajtmh.1983.32.94","article-title":"Pathology of a live attenuated anti-schistosome vaccine in mice","volume":"32","author":"Byram","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0047-0740(80)90027-3","article-title":"Progress in the development of radiation-attenuated vaccines for schistosomiasis","volume":"7","author":"Taylor","year":"1980","journal-title":"Int J Nucl Med Biol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0395","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.133.3455.766","article-title":"New approach to immunization against Schistosoma japonicum","volume":"133","author":"Hsu","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.05.068_b0400","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2307\/3279708","article-title":"Studies on putative adult worm-derived vaccines and adjuvants for protection against Schistosoma mansoni infection in mice","volume":"64","author":"Maddison","year":"1978","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0405","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.3966161","article-title":"Vaccination against Schistosoma mansoni with purified surface antigens","volume":"227","author":"Smith","year":"1985","journal-title":"Science"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2024.05.068_b0410","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1017\/S003118200008570X","article-title":"Molecular cloning of schistosome genes","volume":"92","author":"Taylor","year":"1986","journal-title":"Parasitology"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2024.05.068_b0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/S0074-02762006000900004","article-title":"Schistosome vaccines: a critical appraisal","volume":"101","author":"Wilson","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2024.05.068_b0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13071-016-1369-9","article-title":"Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?","volume":"9","author":"Wilson","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2024.05.068_b0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nyas.13942","article-title":"Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy","volume":"1425","author":"Zhang","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2024.05.068_b0430","doi-asserted-by":"crossref","first-page":"e5900","DOI":"10.1371\/journal.pone.0005900","article-title":"A cluster-randomised intervention trial against Schistosoma japonicum in the Peoples\u2019 Republic of China: bovine and human transmission","volume":"4","author":"Gray","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.05.068_b0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0001-706X(02)00017-7","article-title":"Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People\u2019s Republic of China","volume":"82","author":"Williams","year":"2002","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2024.05.068_b0440","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa0800135","article-title":"A strategy to control transmission of Schistosoma japonicum in China","volume":"360","author":"Wang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0445","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/tropicalmed3020068","article-title":"Schistosome vaccines for domestic animals","volume":"3","author":"You","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0450","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13071-016-1799-4","article-title":"Schistosomiasis vaccines: where do we stand?","volume":"9","author":"Tebeje","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2024.05.068_b0455","doi-asserted-by":"crossref","unstructured":"L\u00e9ger E, Garba A, Hamidou AA, Webster BL, Pennance T, Rollinson D, et al. Introgressed Animal Schistosomes Schistosoma curassoni and S. bovis Naturally Infecting Humans - Volume 22, Number 12\u2014December 2016 - Emerging Infectious Diseases journal - CDC n.d. doi: 10.3201\/eid2212.160644.","DOI":"10.3201\/eid2212.160644"},{"key":"10.1016\/j.vaccine.2024.05.068_b0460","first-page":"tpmd210803","article-title":"Sensitive diagnosis and post-treatment follow-up of Schistosoma mansoni infections in asymptomatic Eritrean refugees by circulating anodic antigen detection and polymerase chain reaction","author":"Hoekstra","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0465","doi-asserted-by":"crossref","unstructured":"Vaillant MT, Philippy F, Barr\u00e9 J, Bulaev D, Garba AT. Diagnostic tests for Schistosomiasis for low prevalence settings: a systematic review and Meta-Analysis. medRxiv 2021.","DOI":"10.1101\/2021.05.05.21256678"},{"key":"10.1016\/j.vaccine.2024.05.068_b0470","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1430","article-title":"Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis","volume":"12","author":"Tran","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0475","doi-asserted-by":"crossref","first-page":"e0006968","DOI":"10.1371\/journal.pntd.0006968","article-title":"Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: a phase 3 randomized, controlled trial in Senegalese children","volume":"12","author":"Riveau","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0480","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/14760584.2021.1951244","article-title":"Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?","volume":"20","author":"Koopman","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.068_b0485","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2\/Alhydrogel\u00ae With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults. clinicaltrials.gov; 2017."},{"key":"10.1016\/j.vaccine.2024.05.068_b0490","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2\/Alhydrogel(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults. clinicaltrials.gov; 2021."},{"key":"10.1016\/j.vaccine.2024.05.068_b0495","unstructured":"Bottazzi ME. A Phase I\/II Trial of the Safety, Immunogenicity, and Efficacy of the Sm-TSP-2\/Alhydrogel\u00ae Schistosomiasis Vaccine in Healthy Exposed Ugandan Adults. clinicaltrials.gov; 2022."},{"key":"10.1016\/j.vaccine.2024.05.068_b0500","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults. clinicaltrials.gov; 2022."},{"key":"10.1016\/j.vaccine.2024.05.068_b0505","unstructured":"Oswaldo Cruz Foundation. Phase 1 Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis. clinicaltrials.gov; 2016."},{"key":"10.1016\/j.vaccine.2024.05.068_b0510","unstructured":"Oswaldo Cruz Foundation. Safety and Immunogenicity Evaluation of the Vaccine Candidate Sm14 Against Schistosomiasis in Senegalese School Children Healthy or Infected With S. Mansoni and\/or S. Haematobium. A Comparative, Randomized, Controlled, Open-label Trial. clinicaltrials.gov; 2019."},{"key":"10.1016\/j.vaccine.2024.05.068_b0515","unstructured":"Tendler M. Safety and Immunogenicity Evaluation of the Vaccine Candidate Sm14 in Combination With the Adjuvant Glucopyranosyl Lipid A (GLA-SE) in Adults Living in Endemic Regions for S. Mansoni and S. Haematobium in Senegal. A Comparative, Randomized, Open-label Trial. clinicaltrials.gov; 2017."},{"key":"10.1016\/j.vaccine.2024.05.068_b0520","unstructured":"University Hospital, Lille. Phase 1 Study Evaluating Safety and Immunological Criteria of Efficacy of the Recombinant Vaccine Candidate Bilhvax Against Schistosomiasis. clinicaltrials.gov; 2013."},{"key":"10.1016\/j.vaccine.2024.05.068_b0525","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1371\/journal.pntd.0001704","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0530","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41591-020-0759-x","article-title":"A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics","volume":"26","author":"Langenberg","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.05.068_b0535","unstructured":"Roestenberg M. Establishing a Female-only Controlled Human Schistosoma Mansoni Infection Model: a Safety and Dose Finding Study (CoHSI2). clinicaltrials.gov; 2021."},{"key":"10.1016\/j.vaccine.2024.05.068_b0540","unstructured":"Roestenberg M. Safety and Protective Efficacy of Repeated Controlled Human Schistosoma Mansoni Infection. clinicaltrials.gov; 2021."},{"key":"10.1016\/j.vaccine.2024.05.068_b0545","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.vaccine.2009.09.047","article-title":"Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.068_b0550","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0264-410X(97)00071-6","article-title":"Human schistosomiasis: potential long-term consequences of vaccination programmes","volume":"15","author":"Chan","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.068_b0555","doi-asserted-by":"crossref","first-page":"e0007349","DOI":"10.1371\/journal.pntd.0007349","article-title":"Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination","volume":"13","author":"Kura","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-017-2227-0","article-title":"Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities","volume":"10","author":"Stylianou","year":"2017","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2024.05.068_b0565","doi-asserted-by":"crossref","first-page":"e0005544","DOI":"10.1371\/journal.pntd.0005544","article-title":"Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines","volume":"11","author":"Alsallaq","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.05.068_b0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-019-3749-4","article-title":"Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison","volume":"12","author":"Collyer","year":"2019","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2024.05.068_b0575","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1016\/j.vaccine.2020.04.078","article-title":"Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration","volume":"38","author":"Kura","year":"2020","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2024.05.068_b0580","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1016\/j.vaccine.2016.11.033","article-title":"A systems approach to vaccine decision making","volume":"35","author":"Lee","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.068_b0585","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/bs.apar.2015.01.002","article-title":"Economic and financial evaluation of neglected tropical diseases","volume":"87","author":"Lee","year":"2015","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2024.05.068_b0590","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2006.05.008","article-title":"The antipoverty vaccines","volume":"24","author":"Hotez","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.068_b0595","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0001-706X(95)91938-5","article-title":"Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis","volume":"59","author":"Guyatt","year":"1995","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2024.05.068_b0600","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/trstmh\/trt109","article-title":"Severe forms of schistosomiasis mansoni: epidemiologic and economic impact in Brazil, 2010","volume":"108","author":"Nascimento","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.05.068_b0605","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760180347","article-title":"The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni","volume":"114","author":"Nascimento","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2024.05.068_b0610","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2024.05.068_b0615","unstructured":"Gavi. Vaccine investment strategy n.d. https:\/\/www.gavi.org\/our-alliance\/strategy\/vaccine-investment-strategy (accessed July 28, 2022)."},{"key":"10.1016\/j.vaccine.2024.05.068_b0620","unstructured":"CDC. CDC - Schistosomiasis - Treatment 2019. https:\/\/www.cdc.gov\/parasites\/schistosomiasis\/treatment.html (accessed July 29, 2022)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:53:18Z","timestamp":1769025198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":124,"alternative-id":["S0264410X24006455"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine value profile for schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126020"}}